SUMO-1 modification of IκBα inhibits NF-κB activation

Molecular Cell

Volumn 2, Issue 2, 1998, Pages 233-239

  Desterro, Joana M P ^a   Rodriguez, Manuel S ^a   Hay, Ronald T ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; DNA BINDING PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MULTIENZYME COMPLEX; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEASOME; RECOMBINANT DNA; RECOMBINANT PROTEIN; SUMO 1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CELL LINE; GENETICS; HUMAN; MACROMOLECULE; METABOLISM; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CYSTEINE ENDOPEPTIDASES; DNA, RECOMBINANT; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1; MACROMOLECULAR SUBSTANCES; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUMO-1 PROTEIN; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINS;

EID: 0032135131     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80133-1     Document Type: Article

References (37)

1. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M.S., Bachelerie, F., Thomas, D., and Hay, R.T. (1995). Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15, 2689-2696.
2. Arenzana-Seisdedos, F., Turpin, P., Rodriguez, M., Thomas, D., Hay, R.T., Virelizier, J.L., and Dargemont, C. (1997). Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 110, 369-378.
3. Saldi, L., Brown, K., Franzoso, G., and Siebenlist, U. (1996). Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IκB-α. J. Biol. Chem. 271, 376-379.
4. Baldwin, A.S. (1996). The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-693.
5. Boddy, M.N., Howe, K., Etkin, L.D., Solomon, E., and Freemont, P.S. (1996). Pic-1, a novel ubiquitin-like protein which interacts with the PML component of amultiprotein complex that is disrupted in acute promyelocytic leukemia. Oncogene 13, 971-982.
6. Bradbury, E.M. (1992). Reversible histone modifications and the chromosome cell-cycle. BioEssays 14, 9-16.
7. Chen, Z.J., Parent, L., and Maniatis, T. (1996). Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862.
8. Ciechanover, A., and Schwartz, A.L. (1998). The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death. Proc. Natl. Acad. Sci. USA 95, 2727-2730.
9. Desterro, J.M.P., Thomson, J., and Hay, R.T. (1997). Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297-300.
10. Hanke, T., Szawlowski, P., and Randall, R.E. (1992). Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 73, 653-660.
11. Hou, D., Cenciarelli, C., Jensen, J.P., Nguygen, H.B., and Weissman, A.M. (1994). Activation-dependent ubiquitination of aT cell antigen receptor subunit on multiple intracellular lysines. J. Biol. Chem. 269, 14244-14247.
12. Jaffray, E., Wood, K.M., and Hay, R.T. (1995). Domain organization of IκBα and sites of interaction with NF-κB p65. Mol. Cell. Biol. 15, 2166-2172.
13. Johnson, E.S., and Blobel, G. (1997). Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799-26802.
14. Johnson, E.S., Ma, P.C.M., Ota, I.M., and Varshavsky, A. (1995). A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270, 17442-17456.
15. Johnson, E.S., Schwienhorst, I., Dohmen, R.J., and Blobel, G. (1997). The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16, 5509-5519.
16. Kamitani, T., Nguyen, H.P., and Yeh, E.T.H. (1997). Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272, 14001-14004.
17. King, R.W., Glotzer, M., and Kirschner, M.W. (1996). Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol. Biol. Cell 7, 1343-1357.
18. Kroll, M., Conconi, M., Desterro, M.J.P., Marin, A., Thomas, D., Friguet, B., Hay, R.T., Virelizier, J.L., Arenzana-Seisdedos, F., and Rodriguez, M.S. (1997). The carboxy-terminus of IκBα determines susceptibility to degradation by the catalytic core of the proteasome. Oncogene 15, 1841-1850.
19. Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107.
20. Mahajan, R., Gerace, L., and Melchior, F. (1998). Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140, 259-270.
21. Matunis, M.J., Coutavas, E., and Blobel, G. (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470.
22. Matunis, M.J., Wu, J.A., and Blobel, G. (1998). SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140, 499-509.
23. Mellits, K.H., Hay, R.T., and Good bourn, S. (1993). Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21, 5059-5066.
24. Muller, S., Matunis, M.J., and Dejean, A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61-70.
25. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z.D., and Rothe, M. (1997). Identification and characterization of an IκB kinase. Cell 90, 373-383.
26. Rodriguez, M.S., Wright, J., Thomson, J., Thomas, D., Baleux, F., Virelizier, J.-L., Hay, R.T., and Arenzana-Seisdedos, F. (1996). Identification of lysine residues required for signal-induced ubiquitination and degradation of IκB-α in vivo. Oncogene 12, 2425-2435.
27. Roff, M., Thomson, J., Rodriguez, M.S., Jacque, J.-M., Baleux, F., Arenzana-Seisdedos, F., and Hay, R.T. (1996). Role of IκBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem. 271, 7844-7854.
28. Saitoh, H., Sparrow, D.B., Shiomi, T., Pu, R.T., Nishimoto, T., Mohun, T.J., and Dasso, M. (1998). Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8, 121-124.
29. Scherer, D.C., Brockman, J.A., Chen, Z., Maniatis, T., and Ballard, D.W. (1995). Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92, 11259-11263.
30. Schwarz, S.E., Matuschewski, K., Liakopoulos, D., Scheffner, M., and Jentsch, S. (1998). The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc. Natl. Acad. Sci. USA 95, 560-564.
31. Seufert, W., Futcher, B., and Jentsch, S. (1995). Role of a ubiquitin-conjugating enzymein degradation of S-phaseand M-phasecyclins. Nature 373, 78-81.
32. Shen, Z.Y., Pardingtonpurtymun, P.E., Comeaux, J.C., Moyzis, R.K., and Chen, D.J. (1996). Ubl1, a human ubiquitin-like protein associating with human Rad51/Rad52 proteins. Genomics 36, 271-279.
33. Sternsdorf, T., Jensen, K., and Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634.
34. Verma, I.M., and Stevenson, J. (1997). IκB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA 94, 11758-11760.
35. Vlach, J., Garcia, A., Jacque, J.M., Rodriguez, M.S., Michelson, S., and Virelizier, J.L. (1995). Induction of SP1 phosphorylation and NF-κB-independent HIV promoter domain activity in T-lymphocytes stimulated by okadaic acid. Virology 208, 753-761.
36. Yaron, A., Gonen, H., Alkalay, I., Hatzubai, A., Jung, S., Beyth, S., Mercurio, F., Manning, A.M., Ciechanover, A., and BenNeriah, Y. (1997). Inhibition of NF-κB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J. 16, 6486-6494.
37. Zabel, U., Henkel, T., Silva, M.D., and Baeuerle, P.A. (1993). Nuclear uptake control of NF-κB by MAD3, an IκB protein present in the nucleus. EMBO J. 12, 201-211.